Ionis Pharmaceuticals

Ionis Pharmaceuticals

World Rank (Aug-2026)
2279
Market Cap (Aug-2026)
9.512 Billion USD
World Rank (Jan-05-2024)
2,137
Market Cap (Jan-05-2024)
7.403 Billion USD
World Rank (Jul-30-2023)
2,651
Market Cap (Jul-30-2023)
5.694 Billion USD
World Rank (Jan-07-2022)
3,683
Market Cap (Jan-07-2022)
4.290 Billion USD
World Rank (Jan-01-2021)
2,027
Market Cap (Jan-01-2021)
7.898 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 894
Headquarters Country
USA
Top Technology Companies in USA
Top Healthcare Companies in USA
Top Pharmaceutical Companies in USA
Nasdaq / NYSE Code
IONS
Employee Count
796
Employee Count as of Date
As on Dec-2022
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
944 Million USD
Annual Operating Income in USD
-382 Million USD
Annual Net Income in USD
-381 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
3,524 Million USD
Total Liabilities in USD
3,035 Million USD
Total Equity in USD
489 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Biotechnology
Technology
Company Website
IONIS PHARMACEUTICALS INC
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Company Profile

Biotechnology company with headquarters is in USA.

Annual Results Summary

IONIS PHARMACEUTICALS - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-2022587-410 (Loss)-269 (Loss)
Dec-2021810-14 (Loss)-28 (Loss)
Dec-2020729-172 (Loss)-451 (Loss)
Dec-20191,122365296
Dec-20181,122-61 (Loss)276
Balance Sheet Summary

Total Assets as on Dec-2022 was 2,533 Million USD.

Total Liabilities as on Dec-2022 was 1,960 Million USD.

Total Equity as on Dec-2022 was 572 Million USD

Founded Year
1989
Stock Exchange
Nasdaq
Frankfurt
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share